Cardinal Health, Inc. (CAH) Shares Sold by First Fiduciary Investment Counsel Inc.

First Fiduciary Investment Counsel Inc. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 150,218 shares of the company’s stock after selling 3,710 shares during the quarter. First Fiduciary Investment Counsel Inc.’s holdings in Cardinal Health were worth $10,053,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of CAH. Bessemer Group Inc. increased its position in shares of Cardinal Health by 1.2% during the second quarter. Bessemer Group Inc. now owns 4,238 shares of the company’s stock valued at $330,000 after acquiring an additional 51 shares during the last quarter. IFP Advisors Inc increased its position in shares of Cardinal Health by 6.8% during the second quarter. IFP Advisors Inc now owns 4,821 shares of the company’s stock valued at $376,000 after acquiring an additional 305 shares during the last quarter. Global X Management Co. LLC increased its position in Cardinal Health by 11.9% in the second quarter. Global X Management Co. LLC now owns 4,421 shares of the company’s stock worth $344,000 after buying an additional 471 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in Cardinal Health by 4.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 1,216,918 shares of the company’s stock worth $94,823,000 after buying an additional 56,974 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its position in Cardinal Health by 49.6% in the second quarter. Advisors Asset Management Inc. now owns 32,543 shares of the company’s stock worth $2,536,000 after buying an additional 10,788 shares during the last quarter. 88.47% of the stock is owned by institutional investors.

Cardinal Health, Inc. (CAH) opened at $60.57 on Thursday. Cardinal Health, Inc. has a twelve month low of $54.66 and a twelve month high of $84.88. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52. The company has a market capitalization of $18,958.01, a price-to-earnings ratio of 11.44, a PEG ratio of 1.74 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period last year, the company earned $1.24 earnings per share. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. research analysts anticipate that Cardinal Health, Inc. will post 4.97 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.05%. The ex-dividend date is Friday, December 29th. Cardinal Health’s payout ratio is currently 53.78%.

A number of analysts have issued reports on the company. Needham & Company LLC reissued a “hold” rating on shares of Cardinal Health in a research report on Sunday, September 10th. Jefferies Group set a $77.00 target price on Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, August 29th. Cowen raised Cardinal Health to a “buy” rating and set a $74.00 target price for the company in a research report on Tuesday, October 10th. Mizuho set a $70.00 target price on Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, October 24th. Finally, Robert W. Baird reissued a “hold” rating and issued a $73.00 target price on shares of Cardinal Health in a research report on Sunday, September 17th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the stock. Cardinal Health currently has an average rating of “Hold” and an average target price of $73.91.

ILLEGAL ACTIVITY WARNING: “Cardinal Health, Inc. (CAH) Shares Sold by First Fiduciary Investment Counsel Inc.” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/12/14/cardinal-health-inc-cah-shares-sold-by-first-fiduciary-investment-counsel-inc.html.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply